BDBM429623 US10550091, No. LC-32::US10947203, No. LC-32

SMILES COc1cc(C(C)C)c(Cl)cc1-n1nnc(c1C)S(=O)(=O)c1ccc(cc1)C(C)(C)C

InChI Key InChIKey=XIQSNHAMCMTORV-UHFFFAOYSA-N

Data  3 IC50  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 429623   

TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataIC50: 2.20E+3nMAssay Description:The time-resolved fluorescence resonance transfer (TR-FRET) hPXR competitive binding assay was performed according to the manufacturer's instruct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2020
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataEC50:  3.40E+3nMAssay Description:The hPXR transactivation assays (PXR agonistic and antagonistic assays) were performed in the HepG2 cells stably expressing FLAG-hPXR and CYP3A4-luci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/7/2020
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataIC50: 2.20E+3nMAssay Description:The time-resolved fluorescence resonance transfer (TR-FRET) hPXR competitive binding assay was performed according to the manufacturer's instruct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataEC50:  3.40E+3nMAssay Description:The hPXR transactivation assays (PXR agonistic and antagonistic assays) were performed in the HepG2 cells stably expressing FLAG-hPXR and CYP3A4-luci...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataIC50: 1.10E+3nMAssay Description:Displacement of BODIPY FL vindoline from GST-tagged human PXR LBD incubated for 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetNuclear receptor subfamily 1 group I member 2(Human)
St. Jude Children''S Research Hospital

US Patent
LigandPNGBDBM429623(US10550091, No. LC-32 | US10947203, No. LC-32)
Affinity DataEC50:  1.80E+3nMAssay Description:Agonist activity at human PXR expressed in HepG2 cells co-expressing luciferase gene under control of CYP3A4 promoter incubated for 24 hrs by lucifer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed